• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    P
    Pharmaceuticals & Biotech.
    SECTOR | 08 Jun 2023

    Q4FY23 review: On the road to recovery

    buy
    Pharmaceuticals & Biotech.
    by ICICI Securities Limited
    ICICI Securities Limited
    In Q4FY23, companies under our coverage delivered 14%/26%/16% YoY increase in revenue/EBITDA/PAT, respectively. Growth was led by better traction across India and US which also supported 214bps improvement in gross margin.
    Copy Link Share on Share on Share on Share on
    Alert  
    More from Pharmaceuticals & Biotech.
    Recommended
    Five Interesting Stocks Today - August 1, 2025
    The Baseline | 01 Aug 2025, 05:05PM
    Market closes lower, Godrej Properties' revenue beats Forecaster estimates by 40% in Q1
    Trendlyne Marketwatch | 01 Aug 2025, 03:57PM
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd